Promising results from another phase of a clinical trial for an immunotherapy drug for mesothelioma, CRS-207, have been released. […]
|
||||
Promising results from another phase of a clinical trial for an immunotherapy drug for mesothelioma, CRS-207, have been released. […] Roswell Park Cancer Institute is working on a promising lung cancer vaccine from Cuba that will be submitted for FDA approval. […] A Missouri state jury awarded an ovarian-cancer victim $72 million to be paid by Johnson & Johnson because of their talcum powder product. […] Recently, the FDA approved Merck immunotherapy drug Keytruda for treatment in non-small cell lung cancer and is bringing hope to mesothelioma patients. […] |